951
Participants
Start Date
August 18, 2021
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Finerenone (Kerendia, BAY94-8862)
Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.
Placebo
Oral tablet; starting at 10 mg or 20 mg; once daily; received in previous interventional Phase 3 trial FIGARO-DKD; no new intervention was administered in this biomarker study.
Taipei Medical University Hospital, Taipei
Chang Gung Memorial Hospital Kaohsiung, Kaohsiung City
Klinik Landstraße - Krankenhaus Rudolfstiftung, Vienna
Zentrum f. klinische Studien Dr. Hanusch GmbH, Vienna
Bispebjerg Hospital, København NV
Illawarra Diabetes Service, Wollongong
Herlev Hospital - Endocrinology dept., Herlev
Steno Diabetes Center Copenhagen, Herlev
Melbourne Renal Research Group, Reservoir
Severance Hospital, Yonsei University Health System, Seoul
DCC 2 - Plovdiv EOOD, Plovdiv
Holbæk Sygehus, Holbæk
Sydvestjysk Sygehus Esbjerg, Endocrinology dept., Esbjerg
Medizinische Universität Graz, Graz
Aarhus Universitetshospital, Skejby, Aarhus N
MHAT Sveti Pantaleymon - Yambol, Yambol
AZ Delta, Roeselaere
Viborg Sygehus, Viborg
UZ Gent, Ghent
Taipei Veterans General Hospital, Taipei
Hospital SAS de Jerez de la Frontera, Jerez de la Frontera
Hallym University Sacred Heart Hospital, Anyang-si
The Nazareth Trust Hospital EMMS, Nazareth
ASST Santi Paolo e Carlo, Milan
Turun yliopistollinen keskussairaala, Turku
Istituto Ricerche Farmacologiche Mario Negri IRCCS, Bergamo
ASST Papa Giovanni XXIII, Bergamo
Lääkärikeskus Minerva, Rauma
Yonsei University Wonju Christian Hospital, Wŏnju
Randolph Medical Associates, Asheboro
Hospital Universitario 12 de Octubre, Madrid
Indago Research & Health Center, Inc., Hialeah
San Marcus Research Clinic, Inc., Miami Lakes
Floridian Clinical Research, LLC, Miami Lakes
Florida Kidney Physicians - Fort Lauderdale, Fort Lauderdale
A.O.U. di Bologna Policlinico S.Orsola Malpighi, Bologna
Taichung Veterans General Hospital, Taichung
Changhua Christian Hospital, Changhua
Kansas City VA Medical Center, Kansas City
Crescent City Clinical Research Center, LLC, Metairie
Terveystalo Oulu, Oulu
Valley Clinical Trials, Inc. - Northridge, Northridge
Saviers Medical Group, Port Hueneme
East-West Medical Research Institute, Honolulu
Moscow State University n.a. M.V. Lomonosov, Moscow
Moscow State Univ. of Med. & Stomatology n.a. A.I. Evdokimov, Moscow
"PHI Central Clinical Hospital RZD-Medicine", Moscow
Clinical Hospital for Emergency Care n.a. N.V.Solovyov, Yaroslavl
First City Clinical Hospital n.a. E.E. Volosevich, Arkhangelsk
Singapore General Hospital, Singapore
National Heart Centre Singapore, Singapore
Regional Clinical Hospital #1 n.a. prof. S.V. Ochapovsky, Krasnodar
Voronezh Regional Clinical Consultancy-Diagnostic Center, Voronezh
City Outpatient Clinic #4, Voronezh
Saratov City Clinical Hospital #9, Saratov
Izhevsk City Clinical Hospital #9, Izhevsk
City Clinical Hospital #13 Nizhny Novgorod, Nizhny Novgorod
Center of cardiology and neurology, Kirov
Sci-Res. Institute of Complex Cardiovascular Disorders, Kemerovo
Kemerovo Regional Clinical Hospital, Kemerovo
Meir Medical Center, Kfar Saba
Edith Wolfson Medical Center, Holon
Clalit Health Services, Midgal Hamea, Tel Aviv
DMC - Diabetes Medical Center, Tel Aviv
Hadassah Hebrew University Hospital Ein Kerem, Jerusalem
Chase Medical Research, LLC, Waterbury
Joslin Diabetes Center, Boston
Clinical Advancement Center, PLLC, San Antonio
"Multiprofile Hospital for Active Treatment St. Ivan Rilski - Gorna Oryahovitsa , Nephrology Department"
"Capital Region , Gentofte Hospital - Cardiology Research"
Queen Mary Hospital, Hong Kong
Prince of Wales Hospital Hong Kong, Shatin
Tung Wah Hospital, Sheung Wan
"Barzilai Medical Center , Nephrology & Hypertension Dept."
"Hospital del Mar , Nephrology Department"
"Far Eastern Memorial Hospital , Nephrology Department"
Fraser Clinical Trials, Inc., New Westminster
Hopital Charles LeMoyne, Greenfield Park
Manna Research (Mirabel), Mirabel
Clinique des Maladies Lipidques de Quebec, Québec
Nefrologicka ambulance, Prague
Holstebro Hospital, Endocrinology dept., Holstebro
Kohnodai Hospital, NC for Global Health and Medicine, Ichikawa
Saiseikai Matsuyama Hospital, Matsuyama
Fukuoka University Chikushi Hospital, Chikushino-shi
Fukuoka Tokushukai Hospital, Kasuga
Kokura Memorial Hospital, Kitakyushu
Steel Memorial Yawata Hospital, Kitakyushu
Shirakawa Kosei General Hospital, Shirakawa
Higashihiroshima Medical Center, Higashihiroshima
Jiyugaoka YAMADA Clinic, Obihiro
Nakakinen Clinic, Naka
Noritake Clinic, Ushiku
Komatsu Municipal Hospital, Komatsu
Shonan Fujisawa Tokushukai Hospital, Fujisawa
Shonan Kamakura General Hospital, Kamakura
Osaka Saiseikai Senri Hospital, Suita
Sugiura Clinic, Kawaguchi
Association of healthcare corporation, Oyama East Clinic, Oyama
Fukuoka University Hospital, Fukuoka
Japanese Red Cross Kumamoto Hospital, Kumamoto
Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki
Kyosokai AMC NISHI-UMEDA Clinic, Osaka
Kitano Hospital, Osaka
Albert Schweitzer Ziekenhuis, locatie Zwijndrecht, Zwijndrecht
Centro Clinico Academico - Braga, Braga
Seoul National University Hospital, Seoul
Korea University Anam Hospital, Seoul
Kyung Hee University Hospital at Gangdong, Seoul
Kangbuk Samsung Hospital, Seoul
"Gerencia de Gestion Integrada A Coruna , Department of Endocrinology and Nutrition"
"Complejo Hospitalario Universitario de Ferrol , Hospital Naval - Unidad de Hipertensión Arterial"
PTC-Primary care Trial Center, Gothenburg
Avdelningen för kliniska prövningar AKP, Örebro
ClinSmart, Uppsala
Lead Sponsor
Bayer
INDUSTRY